老年晚期肺癌高凝状态患者外周血VEGF、MMP-9的表达

刘坤; 朱颖; 董蕙; 杨勇; 陈曦

老年晚期肺癌高凝状态患者外周血VEGF、MMP-9的表达

刘坤¹,
朱颖¹,
董蕙²,
杨勇³,
陈曦²

1. 昆明医科大学附属肿瘤医院干疗科
2. 昆明医科大学附属肿瘤医院姑息医学研究中心
3. 昆明医科大学附属肿瘤医院泌尿科

基金项目:

基金：云南省卫计委内设机构基金资助项目 (2014NS026);

计量
- 文章访问数: 2266
- HTML全文浏览量: 804
- PDF下载量: 74
- 被引次数: 0
出版历程
- 收稿日期: 2016-09-15

Expression of Serum VEGF, MMP-9 in Eldly Patients with Advanced NSCLC in Hypercoagulative State

Liu Kun ¹,
Zhu Ying ¹,
Dong Hui ²,
Yang Yong ³,
Chen Xi ²

Funds:

基金：云南省卫计委内设机构基金资助项目 (2014NS026);

摘要

摘要: 目的研究老年晚期高凝状态肺癌患者外周血中血管内皮生长因子 (VEGF) 与基质金属蛋白酶-9 (MMP-9) 的表达情况.方法采用ELISA法检测VEGF、MMP-9在30例老年晚期高凝状态肺癌和30例无高凝状态的老年晚期肺癌患者血清中的表达水平.结果老年晚期高凝状态肺癌患者外周血VEGF、MMP-9的表达水平分别为 (536±103) pg/m L、 (474±76) ng/m L, 均明显高于无高凝状态的老年晚期肺癌 (433±74) pg/m L、 (362±43) ng/m L, (P<0.05) , 且在老年晚期高凝状态肺癌外周血中VEGF水平与MMP-9的表达存在正相关关系 (r=0.478) , P<0.05, 并其高表达与患者的年龄、临床分期及伴发疾病的数量相关 (P<0.05) .结论 VEGF、MMP-9在老年晚期高凝状态肺癌外周血中高表达, 进一步证实血液高凝状态在一定程度上促进老年晚期肺癌的侵袭转移.
- 老年晚期肺癌高凝状态 /
- 血管内皮生长因子 /
- 基质金属蛋白酶-9
Abstract: Objective To investigate the expression and significance of serum VEGF (vascular endothelial growth factor) and MMP-9 (matrix metalloprotoinase-9) in eldly patients with advanced NSCLC (non-small cell lung cancer) in hypercoagulative state.Methods Serum VEGF and MMP-9 were detected separately by ELISA (enzyme-linked immunosorbent assay) in 30 specimens of the eldly advanced NSCLC patients with hypercoagulative state and without hypercoagulative state.Results The expression level serum VEGF and MMP-9 was 536±103pg/m L and 474±76 ng/m L in the eldly advanced NSCLC patients with hypercoagulative state;which were higher than that in without hypercoagulative samples (433±74 pg/m L and 362±43 ng/m L) (P<0.05) .The higher expression of serum VEGF in the elder advanced NSCLC patients with hypercoagulative was positively correlated with the higher expression of MMP-9 (r=0.478) P<0.05, and which was correlated with the age, the clinical TNM stage and the number of accompanying disease (P<0.05) .Conclusion VEGF and MMP-9 are highly expressed in the eldly advanced NSCLC patients in hypercoagulative state, further confirming that hypercoagulative states to some extent may promote the invasion and metastasis of elderly patients with advanced lung cancer.

HTML全文

参考文献(22)

[1]	[1]FOLSOM A R, ALEKSIC N, PARK E, et al.Prospective study of fibrinolytic factors and incident coronary heart disease.The atherosclerosis risk in communities (ARIC) study[J].Arterioscler Thromb Vasc Biol, 2001, 21 (4) :611-617.
[2]	[2]AHMAD S, ANSARI A A.Therapeutic roles of heparin anticoagulants in cancer and related disorders[J].Med Chem, 2011, 7 (5) :504-506.
[3]陈兴国, 徐海伟, 张临泉, 等.部分恶性肿瘤患者凝血功能的改变与意义[J].检验医学与临床, 2011, 16 (8) :1933-1934.
[4]	[4]CONNOLLY G C, PHIPPS R P, FRANCIS C W, et al.Platelets and cancer-associated thrombosis[J].Semin Oncol, 2014, 41 (3) :308-310.
[5]	[5]HU C, CHEN R, CHEN W.Thrombocytosis is a significant indictor of hypercoagulability, prognosis and recurrence in gastric cancer[J].Exp Ther Med, 2014, 8 (1) :125-132.
[6]张用, 毕建平, 皮国良, 等.国际肺癌研究协会第八版国际肺癌TNM分期修订稿解读[J].肿瘤防治与研究, 2016, 43 (4) :315.
[7]	[7]SPEK C A, VERSTEEG H H, BORENSZTAJN K S, et al.Anticoagulant therapy of cancer patients:Will patient selection increase overall survival[J].Thromb Haemost, 2015, 114 (3) :530-531.
[8]	[8]YAMASHITA Y.Hypercoagulable State in Cancer[J].Rinsho Byori, 2015, 63 (12) :1435-1442.
[9]	[9]LEE A Y, KAMPHUISEN P W, MEYER G, et al.Prevention of deep vein thrombosis in cancer patients[J].Semin Thromb Hemost, 2007, 33 (7) :699-706.
[10]	[10]LEE A Y.Treatment of venous thromboembolism in cancer patients[J].Best Pract Res Clin Haematol, 2009, 22 (1) :93-101.
[11]	[11]FALANGA A, SCHIEPPATI F, RUSSO D, et al.Cancer tissue procoagulant mechanisms and the hypercoagulable state of patients with cancer[J].Semin Thromb Hemost, 2015, 41 (7) :756-764.
[12]田同德, 储真真, 陈信义.恶性肿瘤高凝状态与血瘀证相关性及中医防治对策研究[J].北京中医药, 2009, 28 (6) :425-427.
[13]	[13]KAWAI K, WATANABE T.Colorectal cancer and hypercoagulability[J].Surg Today, 2014, 44 (5) :797-803.
[14]吴秋玲, 陆宏达, 郭继龙, 等.活血化瘀中药治疗恶性肿瘤的探讨[J].世界中西医结合杂志, 2010, 5 (6) :530-531.
[15]	[15]RIEDL J, PABINGER I, AY C, et al.Platelets in cancer and thrombosis[J].Hamostaseologie, 2014, 34 (1) :54-62.
[16]	[16]ZHAO X L, SUN T, CHE N, et al.Promotion of hepaocellular carcimoma metastasis through metalloproteninase activation by epithelial-mesenchymal transition regulator Twist[J].J Cell Mol Med, 2011, 15 (3) 691-700.
[17]	[17]ZHANG Y, WU J Z, ZHANG J Y, et al.Detection of circulating vascular endothelial growth factor and matrix metalloproteinase-9 in non-small cell lung cancer using Luminex multiplex technology[J].Oncol Lett, 2014, 7 (2) :499-506.
[18]	[18]SAISHO S, YASUDA K, MAEDA A, et al.Post-recurrence survival of patients with non-small-cell lung cancer after curative resection with or without induction/adjuvant chemotherapy[J].Interact Cardiovasc Thorac Surg, 2013, 16 (2) :166-172.
[19]苟小丽, 邢时云, 杨卫兵.联合检测外周血CEA、CA125、VEGF、MT及MMP-9在晚期非小细胞肺癌表达的相关性[J].遵义医学院学报, 2014, 37 (2) :204-207.
[20]张慧颖, 高全立.晚期非鳞非小细胞肺癌治疗新进展[J].中国实用医刊, 2014, 41 (11) :79-82.
[21]	[21]OHTA Y, WATANABE Y, TABATA T, et al.Inhibition of Lymp Hnode Metastasis by an Antiangiogenic Agent, TNP2470[J].Br J Cancer, 2007, 75 (4) :5-12.
[22]	[22]WANG J, ZHU C.Anticoagulation in combination with antiangiogenesis and chemotherapy for cancer patients:evidence and hypothesis[J].Onco Targets Ther, 2016, 9 (9) :4737-4746.

相关文章(20)

[1]	纳钊, 杨航, 陈莉, 李传新, 肖晗, 白强. 基质金属蛋白酶7、谷氨酰转移酶、总胆汁酸联合诊断胆道闭锁的临床价值, 昆明医科大学学报. doi: 10.12259/j.issn.2095-610X.S20250416
[2]	吴锡芳, 汪勇, 彭丽莎, 罗洁, 王枫. 血管内皮生长因子-C对鼻咽癌CNE-2细胞小鼠移植瘤的辐射敏感性的影响, 昆明医科大学学报. doi: 10.12259/j.issn.2095-610X.S20221205
[3]	刘演龙, 光雪峰, 尹小龙, 戴海龙. miR-125a-3p对动脉粥样硬化斑块及M1/M2巨噬细胞、MMP-9和VEGF的影响, 昆明医科大学学报. doi: 10.12259/j.issn.2095-610X.S20220915
[4]	李志强, 高红强, 李镜锋, 余杰琦, 王冬冬, 陈刚, 褚光. ICAM-1、MMP-9及NF-κB在胆管癌中的表达及与外周血免疫抑制细胞的关系, 昆明医科大学学报. doi: 10.12259/j.issn.2095-610X.S20211117
[5]	陈思宇, 付帅, 吴勇. 醋酸棉酚对人舌鳞癌Cal-27细胞侵袭性作用的实验研究, 昆明医科大学学报. doi: 10.12259/j.issn.2095-610X.S20201101
[6]	张娜, 何文娴, 杨雪梅, 李桂萍, 崔妍婷, 毋江洪. 贝伐单抗联合顺铂胸腔灌注治疗肺腺癌恶性胸腔积液, 昆明医科大学学报.
[7]	李蓝江, 许冰莹, 杨春艳, 赵川, 田心. 基质金属蛋白酶1在云南汉族口腔鳞癌发病风险中的相关性, 昆明医科大学学报.
[8]	杨科, 单祖建, 周琼华, 王峻峰. 可溶性细胞因子受体及基质金属蛋白酶与胰腺癌的关系, 昆明医科大学学报.
[9]	李璠, 童宗武, 杨崇猛, 李娟娟, 袁云, 吴春云. 血管内皮生长因子在急性甲醇中毒大鼠大脑皮质的表达变化, 昆明医科大学学报.
[10]	沈秀芬, 薛丽, 番寿蕊, 何晓娟, 王雪娇, 余景星, 夏梅花, 尹列芬. 血清VEGF-C、VEGFR-2、3表达水平在急性白血病疗效监测及预后判断中的应用, 昆明医科大学学报.
[11]	梁乃超. 基质金属蛋白酶MMP-9、TIMP-1及VEGF的表达情况与非小细胞肺癌组织侵袭的相关性, 昆明医科大学学报.
[12]	贺小玉. 血清高半胱氨酸蛋白61及结缔组织生长因子水平与肺癌的进展关系, 昆明医科大学学报.
[13]	赵瑜. 人血管内皮生长因子A（VEGFA）的原核载体构建、蛋白表达及鉴定, 昆明医科大学学报.
[14]	何迷. 多西紫杉醇在肝癌细胞裸鼠肝脏移植瘤中对P53、VEGF作用的研究, 昆明医科大学学报.
[15]	苟维杰. 血清VEGF、CA19-9以及OPN水平检测对大肠癌的临床诊断和手术疗效价值, 昆明医科大学学报.
[16]	秦敏丽. 不同焦虑状态对糖尿病患者炎性因子及血管内皮功能的影响, 昆明医科大学学报.
[17]	李璠. 单核细胞趋化蛋白-1和血管内皮生长因子mRNA在急性甲醇中毒大鼠脑组织的表达, 昆明医科大学学报.
[18]	林雁. 内皮素-1与基质金属蛋白酶-2在喉癌中的表达与浸润的相关性研究, 昆明医科大学学报.
[19]	. SDF-1与VEGF在胶质瘤表达中的关系及意义, 昆明医科大学学报.
[20]	. 云南白药对骨折愈合过程中血管内皮生长因子表达的影响, 昆明医科大学学报.